These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12154276)

  • 21. Antiplatelet therapy to prevent recurrent stroke: Three good options.
    Mansoor AH; Mujtaba MT; Silver B
    Cleve Clin J Med; 2013 Dec; 80(12):787-95. PubMed ID: 24307163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of ischaemic stroke--antiplatelets.
    McCabe DJ; Brown MM
    Br Med Bull; 2000; 56(2):510-25. PubMed ID: 11092100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
    Jamieson DG; Parekh A; Ezekowitz MD
    J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [ASS plus dipyridamole or clopidogrel after stroke: what is the best secondary prevention?].
    Einecke D
    MMW Fortschr Med; 2008 May; 150(21):6-7. PubMed ID: 18575244
    [No Abstract]   [Full Text] [Related]  

  • 25. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
    Gebel JM
    J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiplatelet therapies for secondary stroke prevention: an update on clinical and cost-effectiveness.
    Rothlisberger JM; Ovbiagele B
    J Comp Eff Res; 2015 Aug; 4(4):377-84. PubMed ID: 26274799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review.
    Simmons BB; Yeo A; Fung K; ;
    Postgrad Med; 2010 Mar; 122(2):49-53. PubMed ID: 20203455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current status of antiplatelet agents to prevent stroke.
    Field TS; Benavente OR
    Curr Neurol Neurosci Rep; 2011 Feb; 11(1):6-14. PubMed ID: 21104164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in usage of alternative antiplatelet therapy after stroke and transient ischemic attack.
    Hills NK; Johnston SC
    Stroke; 2008 Apr; 39(4):1228-32. PubMed ID: 18323509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on the use of antiplatelet agents in secondary stroke prevention.
    Jamieson DG
    J Natl Med Assoc; 2007 Mar; 99(3):306. PubMed ID: 17393957
    [No Abstract]   [Full Text] [Related]  

  • 31. Discontinuation of antiplatelet study medication and risk of recurrent stroke and cardiovascular events: results from the PRoFESS study.
    Weimar C; Cotton D; Sha N; Sacco RL; Bath PM; Weber R; Diener HC
    Cerebrovasc Dis; 2013; 35(6):538-43. PubMed ID: 23816610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The approach to optimizing stroke care.
    Panagos PD
    Am J Emerg Med; 2008 Sep; 26(7):808-16. PubMed ID: 18774049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiplatelet agents for secondary prevention of ischemic stroke.
    Majid A; Delanty N; Kantor J
    Ann Pharmacother; 2001 Oct; 35(10):1241-7. PubMed ID: 11675854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiplatelet therapy: a neurology perspective.
    Brass LM
    Manag Care; 2000 Oct; 9(10 Suppl):13-5. PubMed ID: 11729420
    [No Abstract]   [Full Text] [Related]  

  • 35. Antiplatelet therapy: a neurology perspective.
    Brass LM
    Manag Care; 2000 May; 9(5 Suppl):15-7. PubMed ID: 11729408
    [No Abstract]   [Full Text] [Related]  

  • 36. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack.
    Adams RJ; Albers G; Alberts MJ; Benavente O; Furie K; Goldstein LB; Gorelick P; Halperin J; Harbaugh R; Johnston SC; Katzan I; Kelly-Hayes M; Kenton EJ; Marks M; Sacco RL; Schwamm LH; ;
    Stroke; 2008 May; 39(5):1647-52. PubMed ID: 18322260
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antithrombotic treatment as primary and secondary prevention of stroke].
    Chukanova EI; Chukanova AS; Nadareyshvili GG; Gulieva MS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10):85-88. PubMed ID: 28635860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiplatelet therapy in peripheral arterial disease.
    Aronow WS
    Curr Drug Targets Cardiovasc Haematol Disord; 2004 Sep; 4(3):265-7. PubMed ID: 15379619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiplatelet therapy.
    Nicholls C; Sani M
    Nurs Older People; 2004 Nov; 16(8):35-6. PubMed ID: 15552503
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiplatelet agents and randomized trials.
    Diener HC
    Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.